BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16548379)

  • 21. [The opsoclonus-myoclonus syndrome].
    de Brabander C; Hoff JI; Tijssen CC; Lammers GJ; Verschuuren JJ
    Ned Tijdschr Geneeskd; 2005 Jan; 149(4):201-4. PubMed ID: 15702740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.
    Tate ED; Allison TJ; Pranzatelli MR; Verhulst SJ
    J Pediatr Oncol Nurs; 2005; 22(1):8-19. PubMed ID: 15574722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome.
    Yiu VW; Kovithavongs T; McGonigle LF; Ferreira P
    Pediatr Neurol; 2001 Jan; 24(1):72-4. PubMed ID: 11182286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.
    Matthay KK; Blaes F; Hero B; Plantaz D; De Alarcon P; Mitchell WG; Pike M; Pistoia V
    Cancer Lett; 2005 Oct; 228(1-2):275-82. PubMed ID: 15922508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
    Catsman-Berrevoets CE; Aarsen FK; van Hemsbergen ML; van Noesel MM; Hakvoort-Cammel FG; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2009 Dec; 53(6):1048-53. PubMed ID: 19672966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis.
    Armstrong MB; Robertson PL; Castle VP
    Pediatr Neurol; 2005 Nov; 33(5):365-7. PubMed ID: 16243225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIG.
    Pranzatelli MR; Tate ED; Kinsbourne M; Caviness VS; Mishra B
    Mov Disord; 2002 Nov; 17(6):1387-90. PubMed ID: 12465092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiple paraneoplastic syndromes occurring in the same patient: clinical, imaging and neuro-pathological documentation].
    Sá G; Correia C; Pires M; Lopes G
    Acta Med Port; 2006; 19(6):489-93. PubMed ID: 17583609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New concepts in paraneoplastic neurological syndromes.
    Honnorat J; Viaccoz A
    Rev Neurol (Paris); 2011 Oct; 167(10):729-36. PubMed ID: 21890156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Paraneoplastic opsoclonus-myoclonus syndrome associated with small-cell lung cancer].
    Margery J; Ferroir JP; Epaud C; Martin C; Milleron B
    Rev Pneumol Clin; 2003 Nov; 59(5 Pt 1):321-4. PubMed ID: 14707930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opsoclonus-myoclonus in an HIV-infected child on antiretroviral therapy--possible immune reconstitution inflammatory syndrome.
    van Toorn R; Rabie H; Warwick JM
    Eur J Paediatr Neurol; 2005; 9(6):423-6. PubMed ID: 16269259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Paraneoplastic neurological syndromes].
    Didelot A; Honnorat J
    Rev Med Interne; 2011 Oct; 32(10):605-11. PubMed ID: 21036427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraneoplastic opsoclonus-myoclonus syndrome associated with malignant fibrous histiocytoma: neuropathological findings.
    Zámecník J; Cerný R; Bartos A; Jerábek J; Bojar M
    Cesk Patol; 2004 Apr; 40(2):63-7. PubMed ID: 15233019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autonomic paraneoplastic neurological syndromes.
    Lorusso L; Hart IK; Ferrari D; Ngonga GK; Gasparetto C; Ricevuti G
    Autoimmun Rev; 2007 Jan; 6(3):162-8. PubMed ID: 17289552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case of Asperger's disorder that may be secondary to opsoclonus-myoclonus syndrome.
    White JG; Lamps C
    Autism; 2002 Dec; 6(4):433-4. PubMed ID: 12540133
    [No Abstract]   [Full Text] [Related]  

  • 36. Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy.
    Pranzatelli MR; Chun KY; Moxness M; Tate ED; Allison TJ
    Pediatr Neurol; 2005 Aug; 33(2):121-6. PubMed ID: 16087057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parainfectious opsoclonus-myoclonus syndrome: high dose intravenous immunoglobulins are effective.
    Glatz K; Meinck HM; Wildemann B
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):279-80. PubMed ID: 12531974
    [No Abstract]   [Full Text] [Related]  

  • 38. Slowly progressive sensory hemisyndrome: unusual presentation of paraneoplastic sensory neuronopathy.
    Nanetti L; Lauria G; Scaioli V; Marchesi C; Salsano E; Lombardi R; Pareyson D
    J Peripher Nerv Syst; 2010 Mar; 15(1):73-4. PubMed ID: 20433608
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma.
    Wirtz PW; Sillevis Smitt PA; Hoff JI; de Leeuw B; Lammers GJ; van Duinen SG; Verschuuren JJ
    J Neurol; 2002 Dec; 249(12):1710-2. PubMed ID: 12529794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
    Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
    Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.